Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2018  |  Volume : 31  |  Issue : 3  |  Page : 762-771

Study of interleukin-18 during antiviral therapy for hepatitis C with sofosbuvir, ribavirin, and interferon in Menoufia hospitals

1 Department of Microbiology and Immunology, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt
2 Department of Internal Medicine, Faculty of Medicine, Menoufia University, Shebin El-Kom, Egypt
3 Department of Microbiology and Immunology, Shebin El-Kom Fever Hospital, Shebin El-Kom, Egypt

Correspondence Address:
Asmaa T.M Esmaeel
Shebin El-Kom, Menoufia Governorate
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/mmj.mmj_554_16

Rights and Permissions

Objectives The objectives of this study were to evaluate the role of interleukin-18 (IL-18) in liver cirrhosis caused by hepatitis C, and to determine the effect of the triple regimen treatment sofosbuvir, ribavirin, and interferon on its serum levels. Background IL-18 is a member of the IL-1 family. Recent studies have suggested that IL-18 plays a role in the pathogenesis of liver damage during acute and chronic hepatitis; furthermore, IL-18 may be involved in the development and progression of liver fibrosis. Patients and methods The present study was carried out on 27 hepatitis C patients and 15 age-matched and sex-matched healthy individuals. All patients were subjected to history taking, complete medical examination, and laboratory investigations for liver and kidney functions. Serum levels of IL-18 were measured by ELISA three times for each patient: the first one was measured before treatment initiation, the second after 1 week of treatment, and the third was measured after 3 months of treatment. Results The serum levels of IL-18 were highly elevated in hepatitis C patients compared with controls (P < 0.001). In addition, we found that serum IL-18 was significantly higher before initiation of treatment, decreased after 1 week of treatment, and it was markedly decreased after 3 months of treatment. Conclusion There is significant elevation in the serum levels of IL-18 in hepatitis C patients. IL-18 concentrations were reduced following a successful course of antiviral treatment.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded63    
    Comments [Add]    

Recommend this journal